The Infinium Global Research analyzes the Implantable Drug Delivery Devices Market over the period of 2018 to 2024. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in global implantable drug delivery devices market. It will help a lot of decision makers to develop strategies and find new opportunities in the global markets of implantable drug delivery devices. The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encouragement the expansion of the implantable drug delivery devices market during the period. The global Implantable drug delivery devices market is projected to grow at a CAGR of 6.22% over the forecast period of 2018-2024.
We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report shall be Revised to 2020-2026.
The Section on the Impact of COVID-19 on this Market is Included in the Report for Free. To Know More Request Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/1304
Rising Number of Coronary Heart Diseases, Glaucoma, Cancer Cases across Worldwide will Primarily Drive the Demand of the Global Implantable Drug Delivery Devices Market
The global implantable drug delivery devices market is set to experience substantial growth over the forecast period. Primarily driven by increasing population, rise in number of cancer cases, growing number of cardiology, ophthalmology abnormalities, trend of contraception and technological advancements. On the other hand, the risk of infection, risk of overdose/under-dose due to technical difficulty of the devices, high cost will likely to restrain the growth of the market. Merger and acquisition activities among leading service providers will enlighten the opportunities for the same market for the growth over the forecast period. The global implantable drug delivery devices market was worth USD 13,499.43 million in 2017 and it is projected to reach USD 20,589.07 million in 2024, expanding at a CAGR of 6.22% between 2018 and 2024.
According to the World Health Organization (WHO), around 30% of the deaths occurred from cardiovascular disease (particularly from coronary heart disease) across worldwide and the number of cases has been rapidly growing. In addition, the worldwide prevalence of glaucoma varies from 2% to 6%, (found highest in the South Africa). In South Korea, prevalence of glaucoma has been increased 54% between 2008 and 2013.
Furthermore, the rising number of cancer cases is another factor that propels the growth of the implantable drug delivery devices market. According to GLOBOCAN, the incidence of cervical cancer is significantly high in North America region as compared to Asia-Pacific region. But high diagnosis and treatment rate of cervical cancer in North America region lower the rate of growth of cervical cancer cases in North America. On the other hand, low cervical cancer screening rate in Asia-Pacific region leads to rapid increment of cases of cervical cancer in Asia-Pacific region.
Rising number of coronary heart diseases, glaucoma, cancer cases across worldwide will primarily drive the demand of the global implantable drug delivery devices market.
Get this Section as a Free Customization in the Report along with Discount on the Study: https://www.infiniumglobalresearch.com/reports/request-discount/1304
Segments in the Implantable Drug Delivery Devices Industry
The report on global Implantable drug delivery devices market covers segments such as, product type, technology and applications. On the basis of product type the global Implantable drug delivery devices market is categorized into coronary drug eluting stent, bio-absorbable stent, implantable contraceptive devices, implantable intraocular devices, drug infusion pumps and brachytherapy seeds. On the basis of technology the global Implantable drug delivery devices market is categorized into bio-degradable, non-biodegradable and smart pills. On the basis ofapplications, the global Implantable drug delivery devices market is categorized into ophthalmology, cardiology, contraceptive, oncology and others.
Key Players of the Implantable Drug Delivery Devices Industry
The report provides profiles of the companies in the global Implantable drug delivery devices market such as, Allergan, Boston Scientific Corporation, Bayer AG, Alimera Sciences, Eyepoint Pharmaceuticals, Mecrk & Co., Inc, Abbott, Valeant Pharmaceuticals and Medtronic.
Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-implantable-drug-delivery-devices-market
Reasons to Buy this Report:
- Comprehensive analysis of global as well as regional markets of the implantable drug delivery devices.
- Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
- Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
- Infinium Global Research– Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.